What type of study is this?

This is a Meta-Analysis study (also classified as: Systematic Review).

What question did this study set out to answer?

To assess the efficacy and safety of non-clotting factor prophylaxis versus on-demand therapy in hemophilia patients.

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Meta-analysis shows non-clotting factor prophylaxis improves outcomes in hemophilia B patients, indicating better clinical decision-making.

To assess the efficacy and safety of non-clotting factor prophylaxis versus on-demand therapy in hemophilia patients.
Systematic review of randomized controlled trials (RCTs) involving hemophilia A and B patients.
Data extraction on annualized bleeding rate, spontaneous and joint bleeds, and patient-reported outcomes.
Meta-analyses conducted using a random-effects model to compare outcomes across therapies.
Non-clotting factor prophylaxis significantly reduced the annualized bleeding rate for all treated bleeds.
Patients reported improved quality of life metrics (Haem-A-QoL total score).
The therapies did not significantly increase the risk of serious adverse events.

Memon et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Meta-analysis shows non-clotting factor prophylaxis improves outcomes in hemophilia B patients, indicating better clinical decision-making.